FAYETTEVILLE, NY, UNITED STATES, January 9, 2026 /EINPresswire.com/ — January is traditionally a peak period for pharmaceutical list price adjustments. The AnalySource team analyzed Wholesale ...
The "Best Practices for Supplier Qualification in Life Science Training Course (May 6th - May 7th, 2026)" has been added to ResearchAndMarkets.com's offering. Conduct thorough supplier qualifications ...
Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...
The "Understanding Active Pharmaceutical Ingredients (APIs) Training Course (Apr 29th - Apr 30th, 2026)" training has been added to ResearchAndMarkets.com's offering. An active pharmaceutical ...
DELRAY BEACH, Fla., Jan. 14, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Pharmaceutical Filtration Consumables ...
Sharp Sterile Manufacturing is investing $28 million to expand equipment at its Lee facility, a move expected to double ...
AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
REZENOPY™ received approval from the U.S. Food and Drug Administration (the "FDA”) on April 19, 2024. The newly issued patent is eligible for listing in the FDA’s Orange Book and, if listed, may ...
Trade Brains on MSN
How will Torrent Pharma benefit from the acquisition of JB Chemicals?
One of the leading Indian pharmaceutical companies engaged in research, development, manufacturing, and marketing of generic ...
Upslope Capital's Q4 2025 letter details new positions in Booz Allen Hamilton and Crown Holdings amid shifting macro ...
Pharma industry experts indicate that strategy in 2026 is shifting to agentic AI, sustainable efficiency, and resilient supply chains to manage tariffs, regulations, and digitalization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback